ОРИГИНАЛЬНОЕ ИССЛЕДОВАНИЕ2026 · pp. 49–56
Bystrova V.I., Shrayner E.V., Lifshits G.I., Kudlay D.A.
Metabolic syndrome (MS) is a cluster of conditions including abdominal obesity, hypertension, dyslipidemia, and hyperglycemia that are very common in developed countries. The prevalence of MS increases annually. In recent years, a significant increase in the p…
ОРИГИНАЛЬНОЕ ИССЛЕДОВАНИЕ2020
Sukhanov D.S., Ivkin D.Yu., Plisko G.A., Karavaeva A.V., Krasnova M.V., Poveryaeva M.A., Karev V.E., Bunyat A.V., Stepanova I.L., Okovityj S.V.
Introduction. In the treatment of non-alcoholic fatty liver disease (NAFLD), which is the main cause of chronic liver disease, a certain role is assigned to hepatoprotectors. One of the hepatoprotectors currently used to treat NAFLD is ademetionine. At the sam…
ОРИГИНАЛЬНОЕ ИССЛЕДОВАНИЕ2017
Kurbatova I.V., Dudanova O.P., Topchieva L.V., Larina A.A.
Introduction. The contribution of caspase-dependent apoptosis in the pathogenesis of nonalcoholic fatty liver disease (NAFLD) is not fully understood. One possible mechanism of hepatoprotective action of ursodeoxycholic acid (UDCA) is the suppression of apopto…